Events & Presentations

Mar 14, 2019
4:30 pm EDT
Mar 14, 2019
Athersys Year End 2018 Results Webcast
Details on Upcoming events are not yet available.

You are about to review past events, which may include webcasts, presentations, and/or earning calls regarding Athersys, Inc. (NASDAQ: ATHX) that contain time-sensitive information. The information contained therein is only current as of the date thereof. Readers are urged to refer to the most recent events and SEC filings for the most current information.

Athersys, Inc. expressly disclaims any obligation to review, update or correct these materials after the date thereof. Athersys, Inc. may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice.

This information is intended for communication with investors and should not be construed as marketing of any Athersys, Inc. product candidates.
 

Mar 5 - Mar 6, 2019
BIO Asia International Conference
Feb 11 - Feb 12, 2019
BIO CEO & Investor Conference
Feb 6 - Feb 8, 2019
International Stroke Conference 2019
Jan 7 - Jan 10, 2019
JP Morgan Healthcare Conference
Additional Information
Athersys will be attending the JP Morgan Healthcare conference, where companies gather to share exciting advances that are driving medical #innovation to help transform clinical care for patients.  
San Francisco, CA
Dec 12, 2018
5:30 pm EST
Dec 12, 2018
ISCT Webinar – Partnering in Japan: The Athersys - Healios Story
Nov 6, 2018
4:30 pm EST
Nov 6, 2018
Athersys Third Quarter 2018 Results Webcast
Additional Information
Telephone access: US and Canada    (800) 273-1254
Telephone access: International    (973) 638-3440
Access code    7396506
Oct 3, 2018 from 5:30 pm to 5:45 pm PDT
Cell & Gene Meeting on the Mesa
Gil Van Bokkelen Ph.D.
Chairman and CEO
Additional Information

Dr. Van Bokkelen will provide a brief overview of the Athersys’ clinical pipeline, focusing on the ongoing Phase 3 trial of MultiStem® cell therapy for the treatment of ischemic stroke that has received Fast Track and RMAT designation from the U.S. Food and Drug Administration, positive scientific advice from the European Medicines Agency, and is being conducted under a Special Protocol Assessment (SPA). 


In addition, Dr. Van Bokkelen has been invited to speak at two conference workshops, where he will describe the Company’s progress working in collaboration with Healios K.K. under the innovative regenerative medicine regulatory framework implemented in Japan as part of the “Doing Business in Japan” workshop. During the “Readiness Strategies for Cell Therapy – Commercial Manufacturing” workshop, Dr. Van Bokkelen will discuss commercial manufacturing approaches and technologies for cellular therapies.

 

Event:     Doing Business in Japan Workshop: Development of an “Off the Shelf” Cell Therapy for Ischemic Stroke and Other Indications Under the Regenerative Medicine Regulatory Framework in Japan
Date:    October 3, 2018
Time:    7:50 – 8:05 am Pacific Time
Location:    Magnolia Room at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037
 

Event:    Athersys Corporate Overview
Date:    October 3, 2018
Time:    5:30 – 5:45 pm Pacific Time
Location:    Ballroom 1 at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037
 

Event:         Readiness Strategies for Cell Therapy – Commercial Manufacturing Workshop, Section 3 Technology
Date:    October 4, 2018
Time:    8:10 – 8:35 am Pacific Time
Location:    Learning Theater at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 9203

 

La Jolla, CA
Ballroom 1 at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037
Aug 7, 2018
4:30 pm EDT
Aug 7, 2018
Athersys Second Quarter 2018 Results Webcast
Additional Information

Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7th, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.  Laura Campbell, Senior Vice President of Finance and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

Date August 7, 2018
Time 4:30 p.m. (Eastern Time)
Telephone access: US and Canada (800) 273-1254
Telephone access: International (973) 638-3440
Access code 5144048
Jun 19, 2018
1:50 pm AEST
Jun 19, 2018
International Society for Stem Cell Research 2018
Sarah Busch, PhD
Associate Director of Regenerative Medicine - 
Athersys, Inc.
Additional Information

Dr. Sarah Busch will present at the Pre-Meeting Education Session II: Cellular Therapy in the Nervous System.

Pre-Meeting Education Schedule

Melbourne, Australia
Walter and Eliza Hall Institute of Medical Research
Jun 18, 2018
11:00 am EDT
Jun 18, 2018
2018 Annual Meeting of the Shareholders
Additional Information

We invite all of our shareholders to attend our annual meeting, scheduled for Monday June 18th at the Westin Cleveland Hotel, located at 777 St. Clair Ave NE in Cleveland.  A continental breakfast will be served at 11 AM and the meeting will follow at 11:30 AM. 

May 10, 2018
4:30 pm EDT
May 10, 2018
Athersys First Quarter 2018 Results Webcast
Additional Information
Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call.
 
Date:  May 10, 2018
Time: 4:30 p.m. (Eastern Time)
Telephone access: US and Canada - (800) 273-1254
Telephone access: International - (973) 638-3440
Access code: 1189915
 
 
Apr 12, 2018
2:10 am EDT
Apr 12, 2018
GTCbio 15th Annual Stem Cell Summit
Dr. Tony Ting
Vice President of Regenerative Medicine and Head of Cardiopulmonary Programs

Boston, MA
United States